Walleye Capital
DFTX

Walleye Capital’s Definium Therapeutics DFTX Stock Holding History

Walleye Capital’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24,900
Closed -$294K – 4924
2025
Q3 		$294K Buy
24,900
+3,700
+17% +$34.5K ﹤0.01% 3021
2025
Q2 		$138K Buy
21,200
+1,300
+7% +$8.55K ﹤0.01% 3604
2025
Q1 		$116K Buy
+19,900
New +$143K ﹤0.01% 3554
2024
Q4 		– Sell
-9,800
Closed -$55.8K – 5275
2024
Q3 		$55.8K Buy
9,800
+4,100
+72% +$28.5K ﹤0.01% 4610
2024
Q2 		$41.1K Buy
+5,700
New +$49.9K ﹤0.01% 4982

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Walleye Capital's DFTX Position: Q1 2026 in Review

Walleye Capital opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 35,485 shares worth $671K. The stake represents ﹤0.01% of the portfolio and ranks #2426 among its holdings. This is a return to the name: Walleye Capital previously reported a position in DFTX as recently as Q3 2025.

Walleye Capital first reported a position in DFTX in Q2 2024 and has held it in 3 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Walleye Capital held 35,485 shares of Definium Therapeutics worth $671K as of Q1 2026.
  • Definium Therapeutics was a new Walleye Capital position in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2426 holding.
  • Walleye Capital first reported a position in Definium Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.